Sensus Healthcare, Inc. (SRTS) closed at $4.16 in the latest trading session, marking a -9.17% move from the prior day. This move lagged the S&P 500's daily loss of 0.33%. Elsewhere, the Dow lost 0.63%, while the tech-heavy Nasdaq lost 0.22%.
The company's stock has dropped by 7.85% in the past month, falling short of the Medical sector's loss of 0.32% and the S&P 500's gain of 4.07%.
The investment community will be closely monitoring the performance of Sensus Healthcare, Inc. in its forthcoming earnings report. The company's earnings per share (EPS) are projected to be $0.01, reflecting a 90% decrease from the same quarter last year. At the same time, our most recent consensus estimate is projecting a revenue of $8.8 million, reflecting a 4.76% fall from the equivalent quarter last year.
SRTS's full-year Zacks Consensus Estimates are calling for earnings of $0.11 per share and revenue of $41.95 million. These results would represent year-over-year changes of -73.17% and +0.34%, respectively.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Sensus Healthcare, Inc. Such recent modifications usually signify the changing landscape of near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Sensus Healthcare, Inc. is currently sporting a Zacks Rank of #5 (Strong Sell).
Looking at its valuation, Sensus Healthcare, Inc. is holding a Forward P/E ratio of 41.64. For comparison, its industry has an average Forward P/E of 23.76, which means Sensus Healthcare, Inc. is trading at a premium to the group.
The Medical – Instruments industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 168, finds itself in the bottom 32% echelons of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
